| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |